Journal of Clinical Epidemiology
Volume 63, Issue 4 , Pages 441-451 , April 2010

Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors

  • Andrea J. Cook

      Affiliations

    • Biostatistics Unit, Group Health Research Institute, Seattle, WA, USA
    • Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. Biostatistics Unit, Group Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA. Tel.: +206-287-4257; fax: +206-287-4710.
    • ,
  • Joann G. Elmore

      Affiliations

    • Department of Medicine, University of Washington School of Medicine, Harborview Medial Center, Seattle, WA, USA
    • ,
  • Diana L. Miglioretti

      Affiliations

    • Biostatistics Unit, Group Health Research Institute, Seattle, WA, USA
    • Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA
    • ,
  • Edward A. Sickles

      Affiliations

    • Department of Radiology, University of California School of Medicine, UCSF Medical Center, San Francisco, CA, USA
    • ,
  • Erin J. Aiello Bowles

      Affiliations

    • Biostatistics Unit, Group Health Research Institute, Seattle, WA, USA
    • ,
  • Gary R. Cutter

      Affiliations

    • Department of Biostatistics, University of Alabama School of Public Health, Birmingham, AB, USA
    • ,
  • Patricia A. Carney

      Affiliations

    • Department of Family Medicine, Oregon Health & Science University, Portland, OR, USA
    • Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR, USA

,Accepted 27 June 2009.

References 

  1. Elmore J, Choe J. Breast cancer screening for women in their 40s: moving from controversy about data to helping individual women. Ann Intern Med. 2007;146:529–531
  2. Elmore JG, Wells CK, Howard DH, Feinstein AR. The impact of clinical history on mammographic interpretations. JAMA. 1997;277:49–52
  3. Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, Malvin K, et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med. 2000;133:855–863
  4. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA. 1996;276:33–38
  5. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997;169:1001–1008
  6. Carney PA, Geller BM, Moffett H, Ganger M, Sewell M, Barlow WE, et al. Current medicolegal and confidentiality issues in large, multicenter research programs. Am J Epidemiol. 2000;152:371–378
  7. Barlow WE, Chi C, Carney PA, Taplin SH, D'Orsi C, Cutter G, et al. Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst. 2004;96:1840–1850
  8. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–175
  9. Yankaskas BC, Taplin SH, Ichikawa L, Geller BM, Rosenberg RD, Carney PA, et al. Association between mammography timing and measures of screening performance in the United States. Radiology. 2005;234:363–373
  10. American College of Radiology . American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Am Coll Radiol. 2003;
  11. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health. 1993;14:43–68
  12. Miglioretti DL, Heagerty PJ. Marginal modeling of multilevel binary data with time-varying covariates. Biostatistics. 2004;5:381–398
  13. Miglioretti DL, Heagerty PJ. Marginal modeling of nonnested multilevel data using standard software. Am J Epidemiol. 2007;165:453–463
  14. Neuhaus JM, McCulloch CE. Separating between- and within-cluster covariate effects by using conditional and partitioning methods. JRSS-B Stat Methodol. 2006;68:859–872
  15. Egger JR, Cutter GR, Carney PA, Taplin SH, Barlow WE, Hendrick RE, et al. Mammographers' perception of women's breast cancer risk. Med Decis Making. 2005;25:283–289
  16. Banks E. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review. J Med Screen. 2001;8(1):29–34
  17. Banks E, Reeves G, Beral V, et al. Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study. BMJ. 2004 May 29;328(7451):1291–1292
  18. Banks E, Reeves G, Beral V, et al. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect. Breast Cancer Res. 2006;8(1):R8
  19. Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet. 2000 Jan 22;355(9200):270–274
  20. Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008;100:563–571
  21. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer. 2006;107:1240–1247
  22. Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs T, Peiro G, et al. Family history of breast cancer, age and benign breast disease. Int J Cancer. 2002;100:375–378
  23. Berg JC, Visscher DW, Vierkant RA, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 2008 March;108(2):167–174
  24. Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res. 2007;13:5474–5479
  25. Degnim AC, Visscher DW, Berman HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007 July 1;25(19):2671–2677
  26. Houssami N, Irwig L, Simpson JM, McKessar M, Blome S, Noakes J. The influence of clinical information on the accuracy of diagnostic mammography. Breast Cancer Res Treat. 2004;85:223–228
  27. Lo JY, Baker JA, Kornguth PJ, Floyd CE. Effect of patient history data on the prediction of breast cancer from mammographic findings with artificial neural networks. Acad Radiol. 1999;6:10–15
  28. Gur D, Bandos AI, Cohen CS, Hakim CM, Hardesty LA, Ganott MA, et al. The “laboratory” effect: comparing radiologists' performance and variability during prospective clinical and laboratory mammography interpretations. Radiology. 2008;249:47–53
  29. Rutter CM, Taplin S. Assessing mammographers' accuracy. A comparison of clinical and test performance. J Clin Epidemiol. 2000;53(5):443–450
  30. Smith-Bindman R, Chu P, Miglioretti DL, et al. Physician predictors of mammographic accuracy. J Natl Cancer Inst. 2005 March 2;97(5):358–367
  31. Taplin S, Abraham L, Barlow WE, Fenton JJ, Berns EA, Carney PA, et al. Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst. 2008;100:876–887

PII: S0895-4356(09)00188-7

doi: 10.1016/j.jclinepi.2009.06.008

Journal of Clinical Epidemiology
Volume 63, Issue 4 , Pages 441-451 , April 2010

Article Tools